Day Traders Tag icon

×
On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.‘s (NASDAQ:MRNA) updated COVID-19 vaccine, which targets the JN.1 variant of SARS-CoV-2. Following the MHRA decision, doses will be available for eligible groups as part of the NHS autumn vaccination program, which is prioritized for use in people at greatest risk of serious illness from COVID-19. Also Read Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales. For the first time in ...


In The news